Skip to main content

Table 2 1 H NMR data for metabolites in rat serum and significant changes of potential biomarkers

From: A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats

No

Metabolitesa

Moieties

δ 1H (multiplicityb)

Selected signal

AMI/

GB/

OD/

SC/

SGBO/

SGB/

Shamc

AMIc

AMIc

AMIc

AMIc

AMIc

1

lipoproteins

CH 3(CH2)n CH 3CH2CH2C=

0.90 (br. t)

 

-

-

-

-

-

-

2

leucine

δ CH3, δ′ CH3, β CH2, γ CH

1.00 (d), 1.02 (d), 1.67 (m), 1.73 (m), 3.75 (m)

 

-

-

-

-

-

-

3

isoleucine

δ CH3, γ′ CH3, γ CH2, β CH, α CH

1.02 (t), 1.07 (d), 1.30 (m), 1.51 (m), 1.99 (m), 3.68 (d)

 

-

-

-

-

-

-

4

valine

γ′ CH3, γ CH3, β CH, α CH

1.05 (d), 1.11 (d), 2.30 (m), 3.66 (d)

 

-

-

-

-

-

-

5

β-HB

CH3, CH2, CH

1.25 (d), 2.29 (m), 2.39 (m), 4.14 (m)

1.25

↓**

-

-

↑**

-

↑*

6

FA

CH3(CH 2)n, CH 2CH2CO, CH 2-C = C, CH 2-C = O, =C-CH 2-C=

1.34 (m), 1.63 (m), 2.09 (m), 2.29 (m), 2.80 (m)

1.34

↑*

-

-

-

-

-

7

lactate

β CH3, α CH

1.39 (d), 4.18 (q)

1.39

↑***

-

-

-

↓***

↓**

8

alanine

β CH3, α CH

1.54 (d), 3.82 (q)

 

-

-

-

-

-

-

9

lysine

γ CH2, δ CH2, β CH2, ϵ CH2, αCH

1.53 (m), 1.75 (m), 1.94 (m), 3.05 (t), 3.83 (t)

 

-

-

-

-

-

-

10

acetate

CH3

1.98 (s)

 

-

-

-

-

-

-

11

NAG

CH3

2.09 (s)

2.09

↑*

-

-

-

-

-

12

OAG

CH3

2.19 (s)

2.19

↑***

-

-

-

↓**

↓**

13

acetone

CH3

2.28 (s)

 

-

-

-

-

-

-

14

acetoacetate

CH3, CH2

2.33 (s), 3.44 (s)

 

-

-

-

-

-

-

15

2-ketoglutarate

β CH2, γ CH2

2.46 (t), 3.03 (t)

 

-

-

-

-

-

-

16

glutamine

β CH2, α CH

2.19 (dd), 2.50 (dd), 3.83 (dd)

 

-

-

-

-

-

-

17

creatine/phosphocreatine

N-CH3, CH2

3.09 (s), 3.99 (s)

3.09

↑**

↓**

-

-

-

-

18

choline

N-(CH3)3, α CH2, β CH2

3.25 (s), 4.09 (t), 3.55 (t)

3.25

↓***

↑*

-

-

↑**

↑*

19

GPC

N-(CH3)3, α CH2, β CH2

3.26 (s), 4.32 (t), 3.69 (t)

3.26

↓***

↑*

-

-

-

↑**

20

PC

N-(CH3)3, α CH2, β CH2

3.27 (s), 4.16 (t), 3.60 (t)

3.27

↓**

↑*

-

-

-

↑*

21

TMAO

CH3

3.32(s)

3.32

↑**

-

-

-

-

-

22

methanol

CH3

3.42 (s)

 

-

-

-

-

-

-

23

glycine

CH2

3.61 (s)

 

-

-

-

-

-

-

24

glycerol

CH, CH2

3.81 (m), 3.71(m), 3.69 (m)

3.69

↑*

-

-

-

-

↓*

25

glucose

α C1H, β C1H, C2H

5.28 (d), 4.69 (d), 3.29 (dd)

5.28 4.69

↑***

↓**

-

-

↓*

↓**

26

PUFA

-CH = CH-, CH2

5.35 (m), 2.83 (m)

5.35

↑**

-

-

-

-

-

27

tyrosine

CH, CH

7.23 (m), 6.94 (m)

7.23

↑**

-

-

-

-

-

28

1-methylhistidine

C4H, C2H

7.09 (s), 7.81 (s)

 

-

-

-

-

-

-

29

phenylalanine

α CH, C2H/ C6H, C4H,C3H/ C5H

3.99 (m), 7.34 (m), 7.39 (m), 7.41 (m)

 

-

-

-

-

-

-

30

formate

H COOH

8.52 (s)

8.52

↑**

-

-

-

-

-

31

albumin

Lysyl-CH2

3.05 (m)

 

-

-

-

-

-

-

  1. aMetabolites: LDL, low density lipoprotein; VLDL, very low density lipoprotein; β-HB, β-hydroxybutyrate; FA, fatty acid; NAG, N-acetyl-glycoprotein; OAG, O-acetyl-glycoprotein; GPC, glycerophosphocholine; PC, phosphocholine; TMAO, trimethylamineoxide; PUFA, polyunsaturated lipids.
  2. bMultiplicity: singlet (s), doublets (d), triplets (t), doublet of doublets (dd), multiplets (m), quartets (q).
  3. cSh/C, G/C, D/C, S/C, SDG/C and SG/C represent sham group, schizandrin group, ophiopogonin D group, ginsenosides group, SDG group, and SG group compared to control group, respectively. ↑ indicates relative increase in signal, ↓ indicates relative decrease in signal, *represents a statistically significant difference (p < 0.05), **represents p < 0.01, ***represents p < 0.001.